BioSpace News Archive

The FDA has so far secured 600 new hires and is looking for 1,600 more as interim leadership at the agency aims to rebuild the workforce and morale after more than a year of intense attrition.

June 24, 2026

·

3 min read

·

Jef Akst

This 3D render features human icons arranged side by side and in a line. Among them, one icon at the front shines brightly, symbolizing leadership and innovation. The visual presents a powerful metaphor for leadership, innovation, and making a difference, making it ideal for themes related to leadership and inspiration in the business world.

FDA

BIO CEO Crowley, DOD doctor Overton are top candidates for FDA commissioner: RBC

A new report from RBC Capital Markets lists Biotechnology Innovation Organization chief executive John Crowley and military physician Heidi Overton as potential candidates for the role of FDA commissioner—in addition to the agency’s current acting leader, top food regulator Kyle Diamantas.

June 24, 2026

·

3 min read

·

Heather McKenzie

Antares Region of the Milky Way, wide angle view

Deals

Novartis, Antares stars align in cancer deal that could top $1.9B

Novartis and Antares Therapeutics are shooting for the stars, launching a joint mission to develop small molecule oncology therapies.

June 24, 2026

·

2 min read

·

Gabrielle Masson

Isometric arrow overcoming above wall on turquoise blue background. Challenge, success, development and solution concept. Flat design. Vector illustration, no transparency, no gradients

Duchenne muscular dystrophy

REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy

A few short days after announcing an FDA pivot on a separate asset, REGENXBIO is planning to test the agency’s apparent newfound rare disease outlook on another late-stage gene therapy.

June 24, 2026

·

2 min read

·

Gabrielle Masson